Home  >  Health Check  >  'Historic' claims for new Alzheimer’s drug
Health Check
'Historic' claims for new Alzheimer’s drug
Health Check
Oct 5, 2022

There’s encouraging news about a potential treatment for Alzheimer’s Disease following years of disappointing drug trials. The drug lecanemab is a monoclonal antibody which is designed to remove clumps of amyloid proteins which damage the brain. Professor Bart de Strooper who’s director of the UK Dementia Research Institute explains how patients who had regular infusions of the drug had their rate of cognitive decline reduced by 27% when compared to those given a placebo.

Sewage testing has been used around the world during the Covid pandemic – and at the moment children in London are being vaccinated against polio after the virus was found in waste water. The BBC’s Health and Science Correspondent James Gallagher takes us on a tour of a sewer in southern England.

Claudia Hammond’s guest this week Professor Graham Easton from Queen Mary University of London looks at whether folic acid could reduce suicide and self harm – and whether it’s ok to take anti-depressants during pregnancy.

Presenter: Claudia Hammond Producer: Paula McGrath

(Picture: Pharmaceutical research into brain disorders. Photo credit: Westend61/Getty Images.)

More Episodes



Apr 22, 2026
Making surgery safer for infants

We learn about a new injectable microgel to help reduce bleeding in infants who require surgical care. In a mice model, it reduced bleeding by at least 50%. Ashley Brown, Professor of Biomedical Engineering at North Carolina State University and UNC Chapel Hill tells presenter Claudia Hammond more about this new material her team has designed.

Joined by Professor of Global Health and Epidemiology at Boston University in the US, Dr Matthew Fox, Claudia hears about a mystery illness that is being investigated by health officials in Burundi, which has caused five deaths and sickened thirty-five people. So far lab analysis of the illness - which causes fever, vomiting, and diarrhoea - has been negative for Ebola and Marburg viruses, Rift Valley fever, and others.

We hear about influential analysis from Cochrane which has concluded that "breakthrough" Alzheimer's drugs are unlikely to benefit patients. Researchers said the impact was "well below" what was needed to make a difference to dementia patients' lives. However, their report has also provoked a vicious backlash from equally esteemed scientists who label it as fundamentally flawed.

We’re joined by health journalist Katie Silver in Mexico, who brings us the news that the President, Claudia Sheinbaum, has announced the details of a plan to introduce universal healthcare – no mean feat in country of 130 million people.

And we hear about an experiment that was done by academics to see if they could trick AI chatbots into believing in an entirely fake disease.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

'Historic' claims for new Alzheimer’s drug

--:--
--:--